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A Genetic Cardiomyopathy Looking for Diagnostic Criteria*Pablo Garcia-Pavia, MD, PHD,y José Luis de la Pompa, PHDzSEE PAGE 1971L eft ventricular noncompaction (LVNC) is arelatively rare cardiomyopathy characterizedby prominent ventricular trabeculations and
deep intertrabecular recesses on the luminal surface
of the left ventricle (1). LVNC can be asymptomatic
or can manifest as depressed systolic function, and
is sometimes accompanied by thromboembolism,
malignant arrhythmias, and heart failure (2,3). The
American Heart Association considers LVNC to be a
distinct primary genetic cardiomyopathy caused by
the arrest of the normal compaction process of the
developing myocardium (4). In contrast, the Euro-
pean Society of Cardiology (ESC) refers to LVNC as
an “unclassiﬁed cardiomyopathy” because LVNC
can appear as a morphological trait of diverse cardio-
myopathies (5). Support for a genetic cause of
LVNC has been obtained through the identiﬁcation
of mutations in the genes that encode the sarco-
meric (6), cytoskeletal (7), and nuclear membrane
proteins (8). Recently, the hypothesis of a develop-
mental basis for LVNC (3) received strong support
from the identiﬁcation in families with LVNC of
deleterious mutations in MIB1, a NOTCH signaling
pathway regulator (9).
Since the initial description of LVNC almost 25
years ago, the cardiac imaging landscape has changed
substantially (10). Advances in imaging diagnostic
technologies have led to better delineation of the
morphological appearance of the myocardium and*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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of Cardiovascular Development and Repair, Centro Nacional de Inves-
tigaciones Cardiovasculares (CNIC), Madrid, Spain. Both authors have
reported that they have no relationships relevant to the contents of
this paper to disclose.reformulation of LVNC imaging diagnostic criteria
(Table 1) (1,11–16). Research over the last decade has
also shown poor agreement among the proposed
diagnostic criteria (17). Moreover, with the increasing
use of cardiac magnetic resonance imaging (CMRI) in
clinical practice, a high number of apparently healthy
individuals have been found to have prominent LV
trabeculations; these individuals fulﬁll the proposed
LVNC criteria. This poses the question of whether
these apparently healthy individuals have a pre-
clinical cardiomyopathy or merely have a normal
variation without the clinical consequences.In this issue of the Journal, Zemrak et al. (18)
conducted a study of more than 2,700 individuals
included in MESA (Multi-Ethnic Study of Atheroscle-
rosis) (18). These investigators determined the num-
ber of healthy individuals included in this long-term
follow-up study who fulﬁlled 1 of the proposed LVNC
criteria (the criteria used in Petersen et al. [13]) and
examined whether these patients had deterioration of
their LV volumes and LV ejection fraction (LVEF)
compared with values measured at the beginning of
the study, almost 10 years before. The investigators
also examined the impact of hypertrabeculation on
the participants’ clinical courses during this period.
They found that 25% of participants exhibited at least
1 cardiac segment with a noncompacted to compacted
(NC/C) ratio >2.3, and that 8% of participants dis-
played 2 or more affected segments (18). Although
LV volumes increased and LVEF decreased in the
9.5 years between the 2 examinations, there were
no differences across themaximal NC/C ratio quintiles,
and patients with greater trabeculations showed even
smaller LV end-diastolic volume changes. Remarkably
(and contrary to previous reports), there were no racial
variations in the maximal NC/C ratio. Finally, adverse
clinical events were scarce in the studied cohort,
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1982despite the apparently high proportion of participants
with a potential unmasked cardiomyopathy.
The investigators should be congratulated for this
work, although some limitations of the study should
be considered. The ﬁrst limitation refers to the LVNC
criteria used. Although frequently used in clinical
practice, the criteria used by Petersen et al. (13) were
derived from a small group of LVNC patients (just 7
individuals) and are the only criteria that used long-
axis views to measure noncompacted cardiac tissue
(Table 1). Most diagnostic criteria require short-axis
views to measure the NC/C ratio because it is easier
to exclude papillary muscles. In long-axis views,
portions of the papillary muscles are imaged and
could be considered as potential trabeculations. Of
note, an elegant CMRI study, in which the maximal
short-axis NC/C ratio was measured in 120 healthy
volunteers, found that only 1 volunteer exhibited a
NC/C ratio >2.3 (19). Other acknowledged limitations
of the Zemrak et al. (18), report were that only 2,754
of the initial 5,004 participants (55%) of the MESA
study were included in the subanalysis, and that, for
technical reasons, trabeculations were not measured
in the initial CMRI studies. This implies that survivor
bias could have inﬂuenced the results and that tra-
beculations did not change over time. Nevertheless,
this report will have immediate consequences in
clinical practice, because due to their simplicity and
high intraobserver and interobserver agreement, the
criteria used by Petersen et al. (13) are the most
frequently used LVNC criteria in CMRI examinations.
The data from this study support cessation of follow-
up in healthy individuals lacking a family history of
cardiomyopathies, but in whom hypertrabeculation
has been found, and pose important challenges for
current LVNC diagnostic criteria.
Zemrak et al. (18) also suggest that despite their
ﬁndings, the LVNC criteria used by Petersen et al. (13)
should still be used according to pre-test disease
probability. Although we agree with the investigators
that pre-test probability is crucial to interpreting all
available criteria (and any other medical test), in our
opinion, the previously mentioned limitations and
the high number of healthy volunteers who fulﬁlled
the criteria used by Petersen et al. (13), make aban-
doning them, in favor of demonstrably superior
criteria, reasonable (14,15).
A sophisticated mathematical technique (fractal
analysis) was recently used to study complex trabe-
culation patterns in LVNC and other cardiomyopa-
thies (15). The results for diagnosis of LVNC and
other entities, such as hypertrophic cardiomyopathy
sarcomere gene mutation carriers without LV hyper-
trophy, are impressive (20). Further studies will tell
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1983us if fractal dimension may become the holy grail of
LVNC diagnosis.
We consider that a deﬁnitive LVNC diagnosis
should be established only in those patients who 1)
fulﬁll a quantitative short-axis diagnostic criterion
(Jenni criteria for echocardiography and Jacquier
criteria for CMRI); and 2) also exhibit 1 of the
following features: LVNC diagnosed in another family
member; regional wall motion abnormalities; LVNC-
related complications (arrhythmia, heart failure, or
thromboembolism); and being a carrier of a patho-
genic mutation in a gene previously associated withLVNC in various families. With regard to the latter,
identiﬁcation of novel disease-causing mutations
using next-generation sequencing techniques and
validation of these mutations in experimental disease
models will contribute to the LVNC diagnosis.
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